114 related articles for article (PubMed ID: 2441479)
21. [Prostatic adenoma. The conservative therapy with urtica extract].
Barsom S; Bettermann AA
ZFA (Stuttgart); 1979 Nov; 55(33):1947-50. PubMed ID: 93356
[No Abstract] [Full Text] [Related]
22. Safety and efficacy of a novel Prunus domestica extract (Sitoprin, CR002) on testosterone-induced benign prostatic hyperplasia (BPH) in male Wistar rats.
Swaroop A; Bagchi M; Kumar P; Preuss HG; Bagchi D
Toxicol Mech Methods; 2015; 25(9):653-64. PubMed ID: 26337762
[TBL] [Abstract][Full Text] [Related]
23. Protective effect of Prostane in experimental prostatic hyperplasia in rats.
Mitra SK; Sundaram R; Mohan AR; Gopumadhavan S; Venkataranganna MV; Venkatesha U; Seshadri SJ; Anturlikar SD
Asian J Androl; 1999 Dec; 1(4):175-9. PubMed ID: 11225890
[TBL] [Abstract][Full Text] [Related]
24. Review of recent placebo-controlled trials utilizing phytotherapeutic agents for treatment of BPH.
Lowe FC; Dreikorn K; Borkowski A; Braeckman J; Denis L; Ferrari P; Gerber G; Levin R; Perrin P; Senge T
Prostate; 1998 Nov; 37(3):187-93. PubMed ID: 9792136
[TBL] [Abstract][Full Text] [Related]
25. The inhibiting effects of Urtica dioica root extracts on experimentally induced prostatic hyperplasia in the mouse.
Lichius JJ; Muth C
Planta Med; 1997 Aug; 63(4):307-10. PubMed ID: 9270373
[TBL] [Abstract][Full Text] [Related]
26. [Treatment of obstructive symptomatology caused by prostatic adenoma with an extract of Serenoa repens. Double-blind clinical study vs. placebo].
Tasca A; Barulli M; Cavazzana A; Zattoni F; Artibani W; Pagano F
Minerva Urol Nefrol; 1985; 37(1):87-91. PubMed ID: 2413558
[No Abstract] [Full Text] [Related]
27. Lack of effects of a lyposterolic extract of Serenoa repens on plasma levels of testosterone, follicle-stimulating hormone, and luteinizing hormone.
Casarosa C; Cosci di Coscio M; Fratta M
Clin Ther; 1988; 10(5):585-8. PubMed ID: 2485240
[TBL] [Abstract][Full Text] [Related]
28. [Medical treatment of the prostatism syndrome. Comparative study].
Martínez Agulló E; Gallego Gómez J; Jiménez Cruz FJ
Arch Esp Urol; 1987 May; 40(4):247-53. PubMed ID: 2443084
[No Abstract] [Full Text] [Related]
29. [An urodynamic study of patients with benign prostatic hypertrophy treated conservatively with phytotherapy or testosterone (author's transl)].
Flamm J; Kiesswetter H; Englisch M
Wien Klin Wochenschr; 1979 Sep; 91(18):622-7. PubMed ID: 90434
[TBL] [Abstract][Full Text] [Related]
30. [Saw palmetto fruit extract for treatment of benign prostatic hyperplasia. Results of a placebo-controlled double-blind study].
Bauer HW; Casarosa C; Cosci M; Fratta M; Blessmann G
MMW Fortschr Med; 1999 Jun; 141(25):62. PubMed ID: 10897913
[No Abstract] [Full Text] [Related]
31. Complementary and alternative medications for benign prostatic hyperplasia.
Keehn A; Lowe FC
Can J Urol; 2015 Oct; 22 Suppl 1():18-23. PubMed ID: 26497340
[TBL] [Abstract][Full Text] [Related]
32. [Prostamol-uno in the treatment of benign prostatic hyperplasia].
Razumov SV; Derevianko II; Sivkov AV
Urologiia; 2001; (2):35-7. PubMed ID: 11490715
[No Abstract] [Full Text] [Related]
33. [Our experience with a hexane extract of Serenoa repens in the treatment of benign prostatic hypertrophy].
Ollé Carreras J
Arch Esp Urol; 1987 Jun; 40(5):310-3. PubMed ID: 2444169
[No Abstract] [Full Text] [Related]
34. [Results of a double-blind study on the effectiveness of ERU (extractum radicis Urticae) capsules in conservative treatment of benign prostatic hyperplasia].
Vontobel HP; Herzog R; Rutishauser G; Kres H
Urologe A; 1985 Jan; 24(1):49-51. PubMed ID: 2580383
[TBL] [Abstract][Full Text] [Related]
35. Phytosterol Pygeum africanum regulates prostate cancer in vitro and in vivo.
Shenouda NS; Sakla MS; Newton LG; Besch-Williford C; Greenberg NM; MacDonald RS; Lubahn DB
Endocrine; 2007 Feb; 31(1):72-81. PubMed ID: 17709901
[TBL] [Abstract][Full Text] [Related]
36. [On the use of a new drug in the therapy of prostatic adenoma: Tadenan. Clinical considerations on 23 cases].
Durval A
Minerva Urol; 1970; 22(3):106-11. PubMed ID: 4099512
[No Abstract] [Full Text] [Related]
37. A Pygeum africanum extract with so-called phyto-estrogenic action markedly reduces the volume of true and large prostatic hypertrophy.
Mathé G; Hallard M; Bourut CH; Chenu E
Biomed Pharmacother; 1995; 49(7-8):341-3. PubMed ID: 8562860
[No Abstract] [Full Text] [Related]
38. Extracts from Pygeum africanum and other ethnobotanical species with antiandrogenic activity.
Schleich S; Papaioannou M; Baniahmad A; Matusch R
Planta Med; 2006 Jul; 72(9):807-13. PubMed ID: 16783690
[TBL] [Abstract][Full Text] [Related]
39. Biological effect of human serum collected before and after oral intake of Pygeum africanum on various benign prostate cell cultures.
Larré S; Camparo P; Comperat E; Boulbés D; Haddoum M; Baulande S; Soularue P; Costa P; Cussenot O
Asian J Androl; 2012 May; 14(3):499-504. PubMed ID: 22198631
[TBL] [Abstract][Full Text] [Related]
40. [New perspectives on the use of Pygeum Africanum in prostato-bladder pathology].
Menchini-Fabris GF; Giorgi P; Andreini F; Canale D; Paoli R; Sarteschi ML
Arch Ital Urol Nefrol Androl; 1988 Sep; 60(3):313-22. PubMed ID: 2975866
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
